Clinical Study Readouts for Novel RNAi Cancer Therapeutics
Time: 9:00 am
day: Day One
Details:
- Advantage of polypeptide nanoparticle delivery for siRNA cancer therapeutics
- STP705 local formulation for treatment of non-melanoma skin cancers
- STP707 systemic formulation for treatment of liver and pancreatic cancers
